Public-private R&D projects are collaborations between various parties, such as knowledge institutions and companies, co-funded by the PPP subsidy from Health~Holland. In these projects, the collaborating parties focus on developing innovative concepts, products, and services in various disciplines, such as medical technology, biopharma, and healthcare. These projects contribute to strengthening the Life Sciences & Health (LSH) sector and offer solutions to challenges in health and care. Health~Holland supports these projects with the PPP subsidy and stimulate collaboration between the different parties.
Central Mission: +5, -30 Doing much more against health inequalities
Mission III: Participating with a disease or disability
Fundamental
(Bio)pharma
NANOCAST 1 and 2, in which Erasmus MC, LUMC and Harbour Antibodies join forces, aims to develop an efficient delivery method for the systemic administration of CRISPR genome editing components to blood stem cells